Irbesartan and Hypercalcaemia - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia is reported as a side effect among people who take Irbesartan (irbesartan), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Hypercalcaemia when taking Irbesartan. It is created by eHealthMe based on reports of 35,908 people who have side effects when taking Irbesartan from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,063 drugs and 1,017 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.

On Jul, 11, 2026

35,908 people reported to have side effects when taking Irbesartan.
Among them, 72 people (0.2%) have Hypercalcaemia.

Among these 72 people:

How long have people been on Irbesartan when they have Hypercalcaemia? *

What is the gender of people who have Hypercalcaemia when taking Irbesartan? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Hypercalcaemia when taking Irbesartan? *

What are other drugs people take besides Irbesartan? *

What are other side effects people have besides Hypercalcaemia? *

Acute Kidney Failure: 16 people, 22.22%
Nausea And Vomiting: 11 people, 15.28%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 13.89%
Fever: 8 people, 11.11%
Anaemia (lack of blood): 8 people, 11.11%
Pneumonia: 6 people, 8.33%
Pericarditis (inflammation of the pericardium): 6 people, 8.33%
Overdose: 6 people, 8.33%
Endocarditis (inflammation in heart muscle): 6 people, 8.33%
Cardiac Infection (an infection of the heart): 6 people, 8.33%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 9 people, 12.50%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 8 people, 11.11%
Type 2 Diabetes: 6 people, 8.33%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 8.33%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 5 people, 6.94%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 4 people, 5.56%
Abdominal Pain: 4 people, 5.56%
Depression: 3 people, 4.17%
High Blood Cholesterol: 2 people, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and have Hypercalcaemia?

- Check whether Hypercalcaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Irbesartan:

Irbesartan (36,414 reports)

Hypercalcaemia treatments and more:

Hypercalcaemia (18,731 reports)

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia:

Hypercalcaemia (1,063 drugs)

Browse all the conditions that are associated with Hypercalcaemia:

Hypercalcaemia (1,017 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Irbesartan) and Irbesartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.